4D Molecular Therapeutics Inc (FDMT) support and resistance · rev $37.0K
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
This page maps 4D Molecular Therapeutics Inc (FDMT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
FDMT currently screens at market cap $518.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FDMT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FDMT quote page for the session range and the stock page for the full model.
Not investment advice.